Device to Detect Skin Cancer with Artificial Intelligence Approved

The artificial intelligence-supported skin cancer detection device of the company named DermaSensor with the same name has been approved by the FDA with its high accuracy rates.

Skin cancer is one of the most common types of cancer in the United States and one of the most common cancers around the world. Treatment possible with early diagnosis Thousands of people die every year due to skin cancer.

Miami-based DermaSensor’s new detection device powered by artificial intelligence is major types of skin cancer, including melanoma It will enable an important step to be taken in early diagnosis.

Provides results in seconds with a simple scan

DermaSensor is a very practical device that can be used in the hand. Physicians only need to scan lesions on the skin with the help of the device. DermaSensor then analyzes the data obtained, It offers an initial assessment in a few seconds. Physicians who use it can request details and have a specialist see the results if they wish.

In this way, it is aimed to strengthen the ability of physicians, especially those working in primary health care, in detecting skin cancer. The aim is to then transfer patients diagnosed with cancer to specialist services such as dermatology and oncology. Briefly, Skin cancer can be easily detected even in a family health center.

So how does the device work?

https://www.youtube.com/watch?v=SX3J_D7rd8E

DermaSensor emits a light when it comes into contact with the skin and is reflected from the cellular structures under the skin surface. It captures and analyzes the wavelengths of light. Thanks to the algorithm it uses, the system instantly evaluates the data and produces the results within seconds.

FDA approval indicates that the device will be used to detect skin cancers. It has 96% sensitivity It is based on research that shows. The rate of benign results in negative results is announced as 97% according to DermaSensor.

The device, which is also commercially available in Australia and Europe, is based on the subscription model of the device. $199 per month for five patients or $399 per month for unlimited use Among the shared information is that it will have pricing.

RELATED NEWS

The thought-provoking reason why people living in Israel once suffered from skin cancer

RELATED NEWS

A New Method Has Been Developed That Succeeds in Destroying 99% of Cancerous Cells

Source :
https://www.reuters.com/business/healthcare-pharmaceuticals/us-fda-clears-dermasensors-ai-powered-skin-cancer-detecting-device-2024-01-17/


source site-36